Movement and Music Intervention for Individuals With Dementia

Overview

The goal of the study is to learn about how possible benefits of movement and music for individuals with dementia. Individuals with dementia will participate in a dance class. The study includes assessments of walking, balance and cognition.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 30, 2017

Detailed Description

Dementia impacts 5%-7% of individuals >60 years old. It impacts the person's ability to perform work, care for him/herself and ultimately leads to physical disability. There is a high caregiver burden associated with dementia and many individuals require care in a long-term care facility. There is some emerging evidence that music based interventions may have a protective effect on the brain in those with dementia. There is also evidence that doing activities that engage the brain through music are beneficial. This study seeks to investigate the potential benefits of a music based intervention for individuals with dementia. The study aims to recruit individuals with a diagnosis of dementia. Once enrolled participants will undergo assessment of walking, balance and cognition and then be asked to participate either in a dance class or to listen to live music. After 6 weeks and again at the end of the study (after 12 weeks) participants will undergo assessments of walking, balance and cognition.

Interventions

  • Other: Dance
    • The primary intervention is a dance class
  • Other: Music
    • the secondary intervention is listening to live music

Arms, Groups and Cohorts

  • Experimental: Dance in dementia
    • examine if participating in a dance class improves mobility and/or cognition in individuals with dementia.
  • Active Comparator: Music and dementia
    • examine if listening to music improves mobility and/or cognition in individuals with dementia.

Clinical Trial Outcome Measures

Primary Measures

  • Timed up and go Cognitive
    • Time Frame: 12 weeks
    • The change in time to complete the Timed Up and Go – Cognitive (TUG-Cog) is recorded in seconds. The participant is timed with a stop watch while walking 3 meters turning and returning to a chair while performing a concurrent cognitive task. This time is compared to the Timed Up and Go (TUG) and the difference in time indicates the effect cognitive deficits have on motor function. Higher scores, indicating more time, means worse outcomes.

Secondary Measures

  • Change in Score on the Montreal Cognitive Assessment
    • Time Frame: 12 weeks
    • The Montreal Cognitive Assessment (MoCA) is an assessment of overall cognitive status. The range of scores is 0-30, with higher scores indicating better outcomes. Scores 26 or higher indicates normal cognitive function.

Participating in This Clinical Trial

Inclusion Criteria

  • Diagnosis of dementia – Mini-Mental State Examination score > 9 – Age > 60 years – Able to follow simple instructions Exclusion Criteria:

  • Unable to walk 10 feet unassisted – Presence of orthopedic disorder that impacts walking – Presence of other neurologic diagnosis that impacts cognitive or motor function such as stroke, Parkinson disease or traumatic brain injury

Gender Eligibility: All

Minimum Age: 60 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Ohio State University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Deb Kegelmeyer, Professor Clinical – Ohio State University
  • Overall Official(s)
    • Deb Kegelmeyer, DPT, Principal Investigator, Ohio State University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.